Afatinib versus gefitinib or erlotinib in first-line setting for Malaysia patients with EGFR mutant advanced lung adenocarcinoma

by Chai, Chee Shee, Liam, Chong Kin, Lin, O. Po, Pang, Yong Kek, Ho, G. F., Alip, A., Wong, C. K., Poh, M. E.
Published 2019

Comparison of planned and measured rectal dose in-vivo during high dose rate Cobalt-60 brachytherapy of cervical cancer

by Zaman, Z.K., Ung, N.M., Malik, R.A., Ho, G.F., Phua, V.C.E., Jamalludin, Z., Baharuldin, M.T.H., Ng, K.H.
Published 2014

Acquired T790M Mutation in Patients Failing Treatment with First or Second-Generation EGFR-Tyrosine Kinase Inhibitors

by Chai, Chee Shee, Liam, Chong Kin, Poh, Mau Ern, Ong, D. B. L., Cheah, P. L., Pang, Yong Kek, Ho, G. F., Alip, A.
Published 2019

Advanced Stage at Presentation Remains a Major Factor Contributing to Breast Cancer Survival Disparity between Public and Private Hospitals in a Middle-Income Country

by Kong, Y.C., Bhoo-Pathy, N., Subramaniam, S., Bhoo-Pathy, N., Mohd Taib, N.A., Jamaris, S., Kaur, K., See, M.H., Ho, G.F., Yip, C.H.
Published 2017

The Predictive Accuracy of PREDICT

by Wong, H.S., Subramaniam, S., Alias, Z., Mohd Taib, N.A., Ho, G.F., Ng, C.H., Yip, C.H., Verkooijen, H.M., Hartman, M., Bhoo-Pathy, N.
Published 2015

Comparison of pattern of disease progression and prevalence of acquired T790M mutation in Malaysia patients with EGFR mutant lung adenocarcinoma upon failure of first-line afatinib...

by Chai, Chee Shee, Lin, O. Po, Liam, Chong Kin, Pang, Yong Kek, Ho, G. F., Alip, A., Wong, Chee Kuan, Poh, Mau Ern, Tan, Jiunn Liang
Published 2019

Adjuvant! online is overoptimistic in predicting survival of Asian breast cancer patients

by Bhoo-Pathy, N., Yip, C.H., Hartman, M., Saxena, N., Taib, N.A., Ho, G.F., Looi, L.M., Bulgiba, A.M., van der Graaf, Y., Verkooijen, H.M.
Published 2012

The impact of the educational environment on career choice and attitudes toward psychiatry

by Wong H.-S., Subramaniam S., Alias Z., Taib N.A., Ho G.-F., Ng C.-H., Yip C.-H., Verkooijen H.M., Hartman M., Bhoo-Pathy N.
Published 2016

The predictive accuracy of PREDICT: A personalized decision-making tool for southeast Asian women with breast cancer

by Wong H.-S., Subramaniam S., Alias Z., Taib N.A., Ho G.-F., Ng C.-H., Yip C.-H., Verkooijen H.M., Hartman M., Bhoo-Pathy N.
Published 2016

Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients

by Bhoo-Pathy, N., Yip, C.-H., Hartman, M., Saxena, N., Taib, N.A., Ho, G.-F., Looi, L.-M., Bulgiba, A.M., Graaf, Y.V.D., Verkooijen, H.M.
Published 2014

Cost-effectiveness of aspirin adjuvant therapy in early stage colorectal cancer in older patients

by Soon S.S., Chia W.-K., Chan M.-L.S., Ho G.F., Jian X., Deng Y.H., Tan C.-S., Sharma A., Segelov E., Mehta S., Ali R., Toh H.-C., Wee H.-L.
Published 2018

A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours

by Ang, Y.L.E., Ho, G.F., Soo, R.A., Sundar, R., Tan, S.H., Yong, W.P., Ow, S.G.W., Lim, J.S.J., Chong, W.Q., Soe, P.P., Tai, B.C., Wang, L., Goh, B.C., Lee, S.-C.
Published 2021

Mindful gratitude journaling: psychological distress, quality of life and suffering in advanced cancer: a randomised controlled trial

by Tan, Ting Ting, Tan, Maw Pin, Lam, Chee Loong, Loh, Ee Chin, David Paul, Capelle, Sheriza Izwa, Zainuddin, Ang, Bin-Ting, Lim, Min Ai, Lai, Natalie Zi, Tung, Yu-Zhen, Yee, Hway Ann, Ng, Chong Guan, Ho, G. F., See, Mee Hoong, Teh, Mei Sze, Lai, Lee Lee, 5 Ranjit Kaur, Pritam Singh, Chai, Chee Shee, Ng, Diana Leh-Ching, Tan, Seng Beng
Published 2021

Adaptation of international guidelines for metastatic colorectal cancer: An Asian consensus

by Cheng,A., Li,J., Vaid,A.K., Ma,B., Teh,C., Ahn,J., Bello,M., Charoentum,C., Chen,L., Lopes,G.D.L., Ho,G.F., Kong,H.L., Lam,K.O., Liu,T.S., Park,Y.S., Sriuranpong,V.R., Sudoyo,A.W., Wang,J., Zhang,J., Zhang,S.Z., Ciardiello,F., Köhne,C.H., Shaw,M., Kim,T.
Published 2015

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

by Li, Jingmei, Lei, Jieping, Rudolph, Anja, Moysich, Kirsten Barbara, Rafiq, Sajjad, Behrens, Sabine, Goode, Ellen L., Pharoah, Paul D P, Seibold, Petra, Fasching, Peter Andreas Ndreas, Andrulis, Irene Louise Irene L, Kristensen V.N., Couch F.J., Hamann U., Hooning M.J., Nevanlinna H., Eilber U., Bolla M.K., Dennis J., Wang Q., Lindblom A., Mannermaa A., Lambrechts D., Garcia-Closas M., Hall P., Chenevix-Trench G., Shah M., Luben R., Haeberle L., Ekici A.B., Beckmann M.W., Knight J.A., Glendon G., Tchatchou S., Alnaes G.I.G., Borresen-Dale A.-L., Nord S., Olson J.E., Hallberg E., Vachon C., Torres D., Ulmer H.-U., Rudiger T., Jager A., van Deurzen C.H.M., Tilanus-Linthorst M.M.A., Muranen T.A., Aittomaki K., Blomqvist C., Margolin S., Kosma V.-M., Hartikainen J.M., Kataja V., Hatse S., Wildiers H., Smeets A., Figueroa J., Chanock S.J., Lissowska J.,Humphreys K., Phillips K.-A., Linn S., Cornelissen S., van den Broek S.A.J., Kang D., Choi J.-Y., Park S.K., Yoo K.-Y., Hsiung C.-N., Wu P.-E., Hou M.-F., Shen C.-Y., Teo S.H., Taib N.A.M., Yip C.H., Ho G.F., Matsuo K., Ito H., Iwata H., Tajima K., Dunning A.M., Benitez J., Czene K., Sucheston L.E., Maishman T., Tapper W.J., Eccles D., Easton D.F., Schmidt M.K., Chang-Claude J.
Published 2016